July 21, 2025 Stanford Physician-Scientist Takes CDER Helm Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs. Conexiant
June 17, 2025 FMT as First-Line CDI Treatment? New randomized trial shows fecal microbiota transplantation may reduce antibiotic dependence in first-episode infections Conexiant
June 23, 2025 Fidaxomicin Effective, Well-Tolerated in Pediatric CDI A multicenter study of pediatric patients treated with fidaxomicin for C difficile found over half were cured by two weeks, and only one in five had a recurrence within two months. Conexiant